CompletedNot Applicable

Pulmonic SAPIEN S3™ THV Registry

Canada, Germany, Switzerland50 participantsStarted 2016-03

Plain-language summary

Multi-center, Observational Registry with Retrospective Enrollment and Prospective Follow-up. The aim of the registry is to document the feasibility and safety of implanting an Edwards SAPIEN S3 transcatheter heart valve in the pulmonic position

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria * Clinical indication and decision for the implantation of an Edwards SAPIEN 3 THV made * Data release form Exclusion Criteria: * none

What they're measuring

changes in right ventricular and pulmonary artery pressure

Timeframe: from baseline to 30 days after implantation

Trial details

NCT IDNCT02777892

SponsorInstitut für Pharmakologie und Präventive Medizin

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2023-03-31

View on ClinicalTrials.gov More Pulmonary Valve Malfunction trials